Kanata firm continued to rewrite its corporate record book, posting year-over-year sales gains in three of its four main service lines en route to hitting another all-time high in quarterly revenues.
Eight entrepreneurs from the National Capital Region are among 10 female business founders taking part in the new program.
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Ottawa firm has seen demand for its products accelerate during the pandemic as companies change gears and train their employees remotely.
Company says it now expects revenues for the current fiscal year to fall between $216 million and $220 million, up from earlier projections of between $211 million and $215 million.
After making a name for itself developing an automated patient reminder system for medical clinics, Cliniconex began to expand into the senior care market in 2018.
Company seeking funding for system it says destroys up to 99 per cent of all germs that come in contact with the UV rays.
An app designed to alert Canadians if they come into close contact with someone infected with COVID-19 can now be downloaded in Ontario.
Companies in six-month program will gain access to technology and expertise from L-Spark’s partners aimed at creating and commercializing cutting-edge medical software and devices.
Bioscience firm that's developing cannabinoid-based treatments for chronic pain is slated to move up from TSX Venture Exchange on Aug. 4.